IRS
Price
$15.25
Change
+$0.10 (+0.66%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
859.33M
IVA
Price
$3.62
Change
+$0.23 (+6.78%)
Updated
Jun 3, 04:58 PM (EDT)
Capitalization
459.4M
113 days until earnings call
Interact to see
Advertisement

IRS vs IVA

Header iconIRS vs IVA Comparison
Open Charts IRS vs IVABanner chart's image
IRSA Inversiones Y Representaciones S.A
Price$15.25
Change+$0.10 (+0.66%)
Volume$990
Capitalization859.33M
Inventiva SA
Price$3.62
Change+$0.23 (+6.78%)
Volume$500
Capitalization459.4M
IRS vs IVA Comparison Chart
Loading...
IRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRS vs. IVA commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRS is a Hold and IVA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (IRS: $15.23 vs. IVA: $3.62)
Brand notoriety: IRS and IVA are both not notable
IRS represents the Real Estate Development, while IVA is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRS: 76% vs. IVA: 954%
Market capitalization -- IRS: $859.33M vs. IVA: $459.4M
IRS [@Real Estate Development] is valued at $859.33M. IVA’s [@Biotechnology] market capitalization is $459.4M. The market cap for tickers in the [@Real Estate Development] industry ranges from $165.37B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Real Estate Development] industry is $5.6B. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRS’s FA Score shows that 2 FA rating(s) are green whileIVA’s FA Score has 0 green FA rating(s).

  • IRS’s FA Score: 2 green, 3 red.
  • IVA’s FA Score: 0 green, 5 red.
According to our system of comparison, IRS is a better buy in the long-term than IVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRS’s TA Score shows that 3 TA indicator(s) are bullish while IVA’s TA Score has 4 bullish TA indicator(s).

  • IRS’s TA Score: 3 bullish, 5 bearish.
  • IVA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both IRS and IVA are a bad buy in the short-term.

Price Growth

IRS (@Real Estate Development) experienced а -2.12% price change this week, while IVA (@Biotechnology) price change was +7.74% for the same time period.

The average weekly price growth across all stocks in the @Real Estate Development industry was +0.88%. For the same industry, the average monthly price growth was +1.22%, and the average quarterly price growth was -3.35%.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

IRS is expected to report earnings on May 07, 2025.

IVA is expected to report earnings on Sep 25, 2025.

Industries' Descriptions

@Real Estate Development (+0.88% weekly)

Activities range from the renovation and re-lease of existing buildings to the purchase of raw land and the sale of developed land or parcels to others. Demand for land development business is driven by GDP growth, employment rates, interest rates, and access to/cost of capital. For individual companies in this industry, proper cost estimation and successful bidding play critical roles in their profitability. Large companies could potentially have greater access to capital, while smaller companies can specialize in a specific geographic area or market niche. CBRE Group, VICI Properties Inc and Brookfield Property Partners L.P. are some of the large companies in this industry.

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRS($859M) has a higher market cap than IVA($459M). IVA YTD gains are higher at: 69.159 vs. IRS (1.474).
IRSIVAIRS / IVA
Capitalization859M459M187%
EBITDA240BN/A-
Gain YTD1.47469.1592%
P/E Ratio3.67N/A-
Revenue94.5BN/A-
Total Cash118BN/A-
Total Debt326BN/A-
FUNDAMENTALS RATINGS
IRS: Fundamental Ratings
IRS
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
15
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRSIVA
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 6 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 6 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 6 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 6 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 6 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 6 days ago
80%
Advances
ODDS (%)
Bullish Trend 15 days ago
84%
Bullish Trend 15 days ago
74%
Declines
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 19 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 6 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRKZX7.40N/A
N/A
PGIM Real Estate Income Z
SDGZX123.55N/A
N/A
DWS Capital Growth R6
REGRX17.40N/A
N/A
Russell Inv Emerging Markets R6
BKGCX15.34N/A
N/A
Baillie Gifford EAFE Plus All Cap K
BTMPX17.71N/A
N/A
iShares MSCI EAFE Intl Idx Inv P